Pharmacokinetics of indoramin in man

British Journal of Clinical Pharmacology
G H DraffanC T Dollery

Abstract

1 The fate of oral and intravenous indoramin has been studied after single doses in man using the 14C labelled drug. Plasma concentrations of indoramin have been determined during chronic oral antihypertensive therapy employing a stable isotope dilution assay. 2 Following singleoral dosing the drug is well absorbed and extensively metabolised. Faecal excretion in 72 h accounts for 46% of the administered radioactivity of which approximately 4% is associated with indoramin. Less than 2% of the radioactivity in urine is accountable as the concentration of total metabolites. Peak plasma levels both of drug and metabolites occur 1-2 h after dosing, the maximal lowering of blood pressure occurring at this time. 3 The clearance of indoramin, determined after intravenous administration is of the same order as liver blood flow. In the isolated perfused rat liver, the extraction ratio is 0.98.

References

May 1, 1974·The Journal of Pharmacy and Pharmacology·G M CohenD S Davies
Dec 1, 1973·European Journal of Clinical Pharmacology·P J LewisC T Dollery
Mar 23, 1972·The New England Journal of Medicine·R ZacestJ Koch-Weser
May 1, 1972·Clinical Pharmacology and Therapeutics·R B RoydsJ D Lockhart
Feb 1, 1973·British Journal of Pharmacology·R C HeadingP Tothill
Jan 1, 1970·Clinical Pharmacology and Therapeutics·D G ShandJ A Oates
Nov 1, 1966·The Biochemical Journal·R HemsH A Krebs

❮ Previous
Next ❯

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·R A FranklinD Stevenson
Jan 1, 1983·European Journal of Clinical Pharmacology·H M NorburyS J Warrington
Jan 1, 1984·European Journal of Clinical Pharmacology·H M NorburyS J Warrington
Jan 1, 1988·European Journal of Clinical Pharmacology·D M PierceR A Franklin
Dec 18, 1978·European Journal of Clinical Pharmacology·D L Clement
Jan 1, 1984·Clinical and Experimental Pharmacology & Physiology·J L Black, E J Mylecharane
Oct 9, 1982·British Medical Journal·R Hunter
Dec 4, 1982·British Medical Journal·P K Marrott, J F Waterfall
Jan 1, 1982·Current Medical Research and Opinion·G N VolansT Frost
Dec 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D M Pierce
Sep 1, 1980·British Journal of Clinical Pharmacology·A JohnstonN A Hamer
Sep 1, 1980·British Journal of Clinical Pharmacology·A J MarshallD W Barritt
May 1, 1989·Human Toxicology·S M AbramsP Turner
Mar 1, 1988·Biopharmaceutics & Drug Disposition·D M PierceR A Franklin
Oct 9, 1982·British Medical Journal·J C StevensonI MacIntyre
Nov 1, 1981·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R A Franklin, D M Pierce
Feb 1, 1986·British Heart Journal·P Collins, D Sheridan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Current Medical Research and Opinion
G N VolansT Frost
European Journal of Clinical Pharmacology
H M NorburyS J Warrington
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
R A Franklin, D M Pierce
© 2021 Meta ULC. All rights reserved